Vernal keratoconjunctivitis treated with omalizumab: A case series

Pediatr Allergy Immunol. 2017 Aug;28(5):503-505. doi: 10.1111/pai.12737.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Child
  • Conjunctivitis, Allergic / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Keratoconjunctivitis / drug therapy*
  • Male
  • Omalizumab / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Allergic Agents
  • Omalizumab